Feminine Pain Relief Patch
NDC Package 71391-130-05
Package Information
Feminine Pain Relief (menthol, unspecified form) patches is for use by Adults and Children 12 years of age and olderApply to the affected area no more than 2 times a dayDry skin completely at application area, before applying the patchOpen pouch and remove patchPeel off protective film and apply sticky side to affected areaIf applied on hairy skin, remove gently using mild warm waterPatch once used, cannot be re-pasted or reusedDispose properly after use. This formulation utilizes a patch delivery system. Marketed by Unexo Life Sciences, Private Limited, this product is identified by NDC 71391-130 and is authorized under FDA application M017.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71391 - Unexo Life Sciences, Private Limited
- 71391-130 - Feminine Pain Relief
- 71391-130-05 - 5 PATCH in 1 POUCH
- 71391-130 - Feminine Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71391-130-05 identifies a specific commercial package of 5 patch in 1 pouch of Feminine Pain Relief, a human over the counter drug labeled by Unexo Life Sciences, Private Limited. This patch is formulated for topical use and contains menthol, unspecified form as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Unexo Life Sciences, Private Limited on January 19, 2019. The current certification is valid through December 31, 2026.
How is this Unexo Life Sciences, Private Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71391013005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.